» Articles » PMID: 30260344

A Novel Guanine N3 Alkylation by Antitumor Antibiotic Duocarmycin A

Overview
Publisher Elsevier
Specialty Chemistry
Date 2018 Sep 28
PMID 30260344
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Antitumor antibiotic duocarmycin A was found to undergo a novel N3 alkylation of the guanine residue (G7) of d(GCAATTGC)2. Guanine base was shown to be a second major target of duocarmycin A in DNA.

Citing Articles

A Comprehensive Review of the Antitumor Properties and Mechanistic Insights of Duocarmycin Analogs.

Morcos A, Jung Y, Galvan Bustillos J, Fuller R, Caba Molina D, Bertucci A Cancers (Basel). 2024; 16(19).

PMID: 39409913 PMC: 11475672. DOI: 10.3390/cancers16193293.


Structural necessity of indole C5-O-substitution of seco-duocarmycin analogs for their cytotoxic activity.

Choi T, Ma E Molecules. 2010; 15(11):7971-84.

PMID: 21060303 PMC: 6259254. DOI: 10.3390/molecules15117971.


Distamycin A modulates the sequence specificity of DNA alkylation by duocarmycin A.

Sugiyama H, Lian C, Isomura M, Saito I, Wang A Proc Natl Acad Sci U S A. 1996; 93(25):14405-10.

PMID: 8962064 PMC: 26145. DOI: 10.1073/pnas.93.25.14405.


Differential effect of duocarmycin A and its novel derivative DU-86 on DNA strand breaks in HeLa S3 cells.

Okamoto A, Asai A, Saito H, Okabe M, Gomi K Jpn J Cancer Res. 1994; 85(12):1304-11.

PMID: 7852193 PMC: 5919396. DOI: 10.1111/j.1349-7006.1994.tb02944.x.